Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PurposeTo determine the minimum inhibitory concentrations (MICs) of 12 antimicrobials in current ophthalmic use and 4 potentially new alternatives against isolates from bacterial keratitis.MethodsBacteria were collected from cases of bacterial keratitis in six centers in the United Kingdom between 2003 and 2006. MICs were measured by using susceptibility strips containing a concentration gradient of the antimicrobials penicillin, cefuroxime, ceftazidime, chloramphenicol, gentamicin, amikacin, vancomycin, teicoplanin, ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, meropenem, linezolid, tigecycline, and daptomycin.ResultsIsolates (n = 772) were collected including coagulase negative Staphylococcus (CNS) (30%), Pseudomonas aeruginosa (23%), Staphylococcus aureus (14%), Enterobacteriaceae (14%), and streptococci (13%). Meropenem had low MICs for most isolates. All isolates except P. aeruginosa were susceptible to tigecycline. Linezolid was active against the majority of Gram-positive pathogens. Ten percent of S. aureus and 20% of CNS isolates were methicillin resistant. When systemic breakpoints were used, 84% of S. aureus isolates were susceptible to ciprofloxacin and 98% to moxifloxacin. Of the P. aeruginosa isolates, 99% were susceptible to ceftazidime, 96% to gentamicin, 99% to ciprofloxacin and 100% to moxifloxacin. More than 97% of Enterobacteriaceae isolates were susceptible to ceftazidime, gentamicin, ciprofloxacin, and moxifloxacin.ConclusionsBased on systemic breakpoint data, resistance to commonly used antimicrobials was apparent. Meropenem is a potentially effective agent for ophthalmic use, with low MICs throughout all the bacterial subgroups. Tigecycline and linezolid showed good activity against particular groups and may be useful for treating bacterial keratitis resistant to current antimicrobials. Of the fluoroquinolones, moxifloxacin showed the lowest MICs and resistance for both Gram-positive and -negative bacteria.

More information Original publication

DOI

10.1167/iovs.09-4638

Type

Conference paper

Publication Date

2010-05-01T00:00:00+00:00

Volume

51

Pages

2519 - 2524

Total pages

5

Addresses

D, e, p, a, r, t, m, e, n, t, , o, f, , O, p, h, t, h, a, l, m, o, l, o, g, y, ,, , R, o, y, a, l, , L, i, v, e, r, p, o, o, l, , U, n, i, v, e, r, s, i, t, y, , H, o, s, p, i, t, a, l, ,, , S, c, h, o, o, l, , o, f, , I, n, f, e, c, t, i, o, n, , a, n, d, , H, o, s, t, , D, e, f, e, n, c, e, ,, , U, n, i, v, e, r, s, i, t, y, , o, f, , L, i, v, e, r, p, o, o, l, ,, , L, i, v, e, r, p, o, o, l, ,, , U, n, i, t, e, d, , K, i, n, g, d, o, m, ., , h, s, u, e, k, e, @, g, m, a, i, l, ., c, o, m

Keywords

Humans, Bacteria, Eye Infections, Bacterial, Corneal Ulcer, Ophthalmic Solutions, Anti-Bacterial Agents, Microbial Sensitivity Tests, Drug Resistance, Bacterial